170 related articles for article (PubMed ID: 36822892)
21. Whipple's disease review, prevalence, mortality, and characteristics in the United States: A cross-sectional national inpatient study.
Ahmad AI; Wikholm C; Pothoulakis I; Caplan C; Lee A; Buchanan F; Kyoo Cho W
Medicine (Baltimore); 2022 Dec; 101(49):e32231. PubMed ID: 36626499
[TBL] [Abstract][Full Text] [Related]
22. Tropheryma whipplei and Whipple's disease.
Fenollar F; Lagier JC; Raoult D
J Infect; 2014 Aug; 69(2):103-12. PubMed ID: 24877762
[TBL] [Abstract][Full Text] [Related]
23. Whipple's disease and Tropheryma whipplei infections: from bench to bedside.
Boumaza A; Ben Azzouz E; Arrindell J; Lepidi H; Mezouar S; Desnues B
Lancet Infect Dis; 2022 Oct; 22(10):e280-e291. PubMed ID: 35427488
[TBL] [Abstract][Full Text] [Related]
24. Erythema nodosum-like lesions in treated Whipple's disease: signs of immune reconstitution inflammatory syndrome.
Schaller J; Carlson JA
J Am Acad Dermatol; 2009 Feb; 60(2):277-88. PubMed ID: 19150271
[TBL] [Abstract][Full Text] [Related]
25. Tumor Necrosis Factor Inhibitors Exacerbate Whipple's Disease by Reprogramming Macrophage and Inducing Apoptosis.
Boumaza A; Mezouar S; Bardou M; Raoult D; Mège JL; Desnues B
Front Immunol; 2021; 12():667357. PubMed ID: 34093562
[No Abstract] [Full Text] [Related]
26. Constrictive pleuropericarditis: a dominant clinical manifestation in Whipple's disease.
Stojan G; Melia MT; Khandhar SJ; Illei P; Baer AN
BMC Infect Dis; 2013 Dec; 13():579. PubMed ID: 24321135
[TBL] [Abstract][Full Text] [Related]
27. Epidemiology of Whipple's Disease in the USA Between 2012 and 2017: A Population-Based National Study.
Elchert JA; Mansoor E; Abou-Saleh M; Cooper GS
Dig Dis Sci; 2019 May; 64(5):1305-1311. PubMed ID: 30488239
[TBL] [Abstract][Full Text] [Related]
28. Tropheryma whipplei aortic valve endocarditis without systemic Whipple's disease.
Chan V; Wang B; Veinot JP; Suh KN; Rose G; Desjardins M; Mesana TG
Int J Infect Dis; 2011 Nov; 15(11):e804-6. PubMed ID: 21880531
[TBL] [Abstract][Full Text] [Related]
29. [Whipple's disease].
Martin-Iguacel R; Clark PS; Barfod TS
Ugeskr Laeger; 2014 Jan; 176(2A):V05130309. PubMed ID: 25346310
[TBL] [Abstract][Full Text] [Related]
30. Whipple's Disease Presenting With a Chief Complaint of Dyspnea and Cough From Pulmonary Invasion Without Evidence of Gastrointestinal Involvement.
Ladna M; George J; Forsmark CE
Cureus; 2024 Feb; 16(2):e54554. PubMed ID: 38516502
[TBL] [Abstract][Full Text] [Related]
31. Tropheryma whipplei infection and Whipple's disease.
Marth T; Moos V; Müller C; Biagi F; Schneider T
Lancet Infect Dis; 2016 Mar; 16(3):e13-22. PubMed ID: 26856775
[TBL] [Abstract][Full Text] [Related]
32. Another Whipple's triad? Pericardial, myocardial and valvular disease in an unusual case presentation from a Canadian perspective.
Thornton CS; Wang Y; Köebel M; Bernard K; Burdz T; Maitland A; Ferraz JG; Beck PL; Ferland A
BMC Cardiovasc Disord; 2019 Dec; 19(1):312. PubMed ID: 31870305
[TBL] [Abstract][Full Text] [Related]
33. Whipple's disease.
Laeeq SM; Luck NH; Hassan SM; Abbas Z; Tasneem AA; Mubarak M
J Coll Physicians Surg Pak; 2014 May; 24 Suppl 2():S81-3. PubMed ID: 24906280
[TBL] [Abstract][Full Text] [Related]
34. Ophthalmic manifestations of Whipple's disease.
Rasool N
Curr Opin Ophthalmol; 2024 Jan; 35(1):83-88. PubMed ID: 37830937
[TBL] [Abstract][Full Text] [Related]
35. Impaired immune functions of monocytes and macrophages in Whipple's disease.
Moos V; Schmidt C; Geelhaar A; Kunkel D; Allers K; Schinnerling K; Loddenkemper C; Fenollar F; Moter A; Raoult D; Ignatius R; Schneider T
Gastroenterology; 2010 Jan; 138(1):210-20. PubMed ID: 19664628
[TBL] [Abstract][Full Text] [Related]
36. Efficacy of ceftriaxone or meropenem as initial therapies in Whipple's disease.
Feurle GE; Junga NS; Marth T
Gastroenterology; 2010 Feb; 138(2):478-86; quiz 11-2. PubMed ID: 19879276
[TBL] [Abstract][Full Text] [Related]
37. Whipple's disease: Rare case of malabsorption with hyperpigmentation in a female.
Munjal Y; Munjal SD; Tiwari R
Indian J Pathol Microbiol; 2021; 64(4):788-790. PubMed ID: 34673605
[TBL] [Abstract][Full Text] [Related]
38. Reduced peripheral and mucosal Tropheryma whipplei-specific Th1 response in patients with Whipple's disease.
Moos V; Kunkel D; Marth T; Feurle GE; LaScola B; Ignatius R; Zeitz M; Schneider T
J Immunol; 2006 Aug; 177(3):2015-22. PubMed ID: 16849516
[TBL] [Abstract][Full Text] [Related]
39. Neurologic disease in patients with treated Whipple's disease.
Knox DL; Bayless TM; Pittman FE
Medicine (Baltimore); 1976 Nov; 55(6):467-76. PubMed ID: 63101
[TBL] [Abstract][Full Text] [Related]
40. Tropheryma whipplei as a commensal bacterium.
Keita AK; Raoult D; Fenollar F
Future Microbiol; 2013 Jan; 8(1):57-71. PubMed ID: 23252493
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
